CPKC 119 NB passing mile 86 MacTier Subdivision with leaders CP 8909, KCSM 4571, CP 6231, CMQ 9020 midway CP 9735 at 09:42 April 28, 2024 #PEDENRAILFAN
Moshe Ornstein MD Cleveland Clinic provided guidance on dosing and toxicity concerns in a patient treated with lenvatinib + pembrolizumab for advanced #RCC . #KCSM
targetedonc.com/view/ornstein-…
📢European Association of Urology (EAU) interview with Phillip Pierorazio about the role of SABR for primary #kidneycancer . Some penetrating questions prompted by FASTRACK II trial;
➡️ What do you counsel patients about long-term complications?
➡️ Is surgery possible after #radonc ?
shorturl.at/blzKL
#kcsm
Experts in RCC Discuss Treatment Goals in the Third-Line Setting #KCSM | Sumanta K. Pal, MD, FASCO City of Hope Thomas Hutson, DO, PharmD, PhD FACP Rana McKay UC San Diego Health
targetedonc.com/view/rcc-treat…